As of Aug 17
| -0.09 / -3.01%|
The 6 analysts offering 12-month price forecasts for Synergy Pharmaceuticals Inc have a median target of 11.00, with a high estimate of 15.00 and a low estimate of 3.20. The median estimate represents a +279.31% increase from the last price of 2.90.
The current consensus among 6 polled investment analysts is to Buy stock in Synergy Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.